Saffet Guleryuz

Preclinical evaluation of TSPO ligand [18F]PBR06 for PET imaging of glioma

E. McKinley, A. Fu, Dewei Tang, 2010 .

Allosteric inhibition of the epidermal growth factor receptor through disruption of transmembrane interactions

M. Buck, F. Barrera, A. Sahoo, 2022, bioRxiv.

Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.

R Adam Smith, Saffet Guleryuz, H Charles Manning, 2011, Frontiers in bioscience.

18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer

E. McKinley, P. Gokhale, J. Bugaj, 2011, Clinical Cancer Research.

Allosteric inhibition of the epidermal growth factor receptor through disruption of transmembrane interactions

M. Buck, F. Barrera, Soyeon Kim, 2023, bioRxiv.

Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline

Eliot T. McKinley, D. Colvin, M. Ansari, 2011, The Journal of Nuclear Medicine.

USE OF 18 FDG-PET IMAGING TO PREDICT TREATMENT RESPONSE TO IGF-1 R / IR TARGETED THERAPY IN LUNG CANCER

Eliot T. McKinley, E. McKinley, J. Bugaj, 2011 .

18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer

Eliot T. McKinley, P. Gokhale, J. Bugaj, 2011, Clinical Cancer Research.